{"entity":{"type":"insider","cik":"0001553595","url":"/insider/0001553595","json_url":"/insider/0001553595.json","name":"Shannon John Patrick Jr","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2013-02-14","last":"2026-01-06","span_basis":"filed_date"},"name_variants":[{"name":"Shannon John Patrick Jr","source":"filing","n_filings":9,"first_seen":"2013-02-14","last_seen":"2026-01-06"}],"transactions":[{"id":5801421,"accession":"0001553595-26-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001553595-26-000002","line_url":"/filing/0001553595-26-000002#line-4","is_derivative":false,"issuer_cik":"0001553595","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001553595","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24907.0,"shares_display":"24,907","price_per_share":7.0766,"price_display":"7.08","price_state":"stated","total_value":176256.8762,"total_display":"176,256.88","total_whole":"176,257","shares_owned_after":2705346.0,"shares_owned_after_display":"2,705,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":4820725,"accession":"0001553595-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001553595-25-000004","line_url":"/filing/0001553595-25-000004#line-2","is_derivative":false,"issuer_cik":"0001553595","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001553595","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23242.0,"shares_display":"23,242","price_per_share":7.4607,"price_display":"7.46","price_state":"stated","total_value":173401.5894,"total_display":"173,401.59","total_whole":"173,402","shares_owned_after":2643153.0,"shares_owned_after_display":"2,643,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":8490877,"accession":"0001867096-23-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-23-000145","line_url":"/filing/0001867096-23-000145#line-1","is_derivative":false,"issuer_cik":"0001553595","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001553595","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30769.0,"shares_display":"30,769","price_per_share":1.638,"price_display":"1.64","price_state":"stated","total_value":50399.622,"total_display":"50,399.62","total_whole":"50,400","shares_owned_after":1408575.0,"shares_owned_after_display":"1,408,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-17","scope":"insider"},{"id":4917114,"accession":"0001867096-21-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001867096-21-000077","line_url":"/filing/0001867096-21-000077#line-2","is_derivative":false,"issuer_cik":"0001553595","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001553595","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":126000.0,"total_display":"126,000.00","total_whole":"126,000","shares_owned_after":363829.0,"shares_owned_after_display":"363,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-12","filed_date":"2021-11-12","scope":"insider"},{"id":4917112,"accession":"0001867096-21-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-21-000077","line_url":"/filing/0001867096-21-000077#line-1","is_derivative":false,"issuer_cik":"0001553595","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001553595","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.0875,"price_display":"2.09","price_state":"stated","total_value":83500.0,"total_display":"83,500.00","total_whole":"83,500","shares_owned_after":303829.0,"shares_owned_after_display":"303,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider"},{"id":2057581,"accession":"0000899243-20-013088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-013088","line_url":"/filing/0000899243-20-013088#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":3.5452,"price_display":"3.55","price_state":"stated","total_value":77994.4,"total_display":"77,994.40","total_whole":"77,994","shares_owned_after":117493.0,"shares_owned_after_display":"117,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-14","scope":"insider"},{"id":2375726,"accession":"0000899243-20-012625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-012625","line_url":"/filing/0000899243-20-012625#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7886.0,"shares_display":"7,886","price_per_share":3.198,"price_display":"3.20","price_state":"stated","total_value":25219.428,"total_display":"25,219.43","total_whole":"25,219","shares_owned_after":95493.0,"shares_owned_after_display":"95,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-11","scope":"insider"},{"id":2244084,"accession":"0000899243-20-004914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-004914","line_url":"/filing/0000899243-20-004914#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12048.0,"shares_display":"12,048","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":49999.2,"total_display":"49,999.20","total_whole":"49,999","shares_owned_after":22607.0,"shares_owned_after_display":"22,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider"},{"id":6384239,"accession":"0001209191-14-052202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-052202","line_url":"/filing/0001209191-14-052202#line-1","is_derivative":false,"issuer_cik":"0001544116","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001544116","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":13.72,"price_display":"13.72","price_state":"stated","total_value":41160.0,"total_display":"41,160.00","total_whole":"41,160","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-13","scope":"insider"},{"id":4767675,"accession":"0001181431-13-009826","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-009826","line_url":"/filing/0001181431-13-009826#line-1","is_derivative":false,"issuer_cik":"0001544116","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001544116","owner_cik":"0001553595","owner_name":"Shannon John Patrick Jr","owner_display_name":"Shannon John Patrick Jr","owner_url":"/insider/0001553595","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":72000.0,"total_display":"72,000.00","total_whole":"72,000","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2013-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Director, Officer","n_filings":4,"first_seen":"2021-11-12","last_seen":"2026-01-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Officer","n_filings":3,"first_seen":"2020-02-18","last_seen":"2020-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2013-02-14","last_seen":"2014-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553595","retrieved_at":"2026-08-25T06:26:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}